ABSTRACTThe incidence of hetero-intermediate glycopeptide susceptibility among Staphylococcus aureus isolates in Malta, a country with a high incidence of methicillin resistance, was studied by screening 454 non-repetitive S. aureus isolates on teicoplanin-supplemented agar plates, followed by Etests and genotypic studies. All strains were susceptible to vancomycin, but four (0.88%) exhibited teicoplanin MICs of > 12 mg/L. High methicillin-resistant S. aureus endemicity was not an accurate predictor of the emergence of non-susceptibility to glycopeptides
The glycopeptides (particularly vancomycin) have been the recommended therapy for serious methicilli...
AbstractVancomycin resistance in Staphylococcus aureus has emerged over the last ten years due to va...
We evaluated, by an improved susceptibility testing method, the prevalence and significance of low-l...
The incidence of hetero-intermediate glycopeptidesusceptibility among Staphylococcus aureusisolates ...
The incidence of hetero-intermediate glycopeptidesusceptibility among Staphylococcus aureusisolates ...
The incidence of hetero-intermediate glycopeptidesusceptibility among Staphylococcus aureusisolates ...
The incidence of hetero-intermediate glycopeptidesusceptibility among Staphylococcus aureusisolates ...
ABSTRACTClinical isolates of methicillin-resistant Staphylococcus aureus (n = 1070) collected from 6...
ABSTRACTStaphylococcus aureus isolates were screened for reduced susceptibility to glycopeptides wit...
ABSTRACTStaphylococcus aureus strains with decreased susceptibility to glycopeptides (GISA) have bee...
Glycopeptide resistance in Staphylococcus aureus is a source of great concern because, especially in...
Objectives To determine the incidence of Staphylococcus aureus isolates with reduced susceptibility ...
AbstractMethicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen worldwide....
International audienceOBJECTIVES: Glycopeptides are the drugs of choice to treat infections due to m...
Abstract : Staphylococcus aureus with resistance to glycopeptide antibiotics has been considered to ...
The glycopeptides (particularly vancomycin) have been the recommended therapy for serious methicilli...
AbstractVancomycin resistance in Staphylococcus aureus has emerged over the last ten years due to va...
We evaluated, by an improved susceptibility testing method, the prevalence and significance of low-l...
The incidence of hetero-intermediate glycopeptidesusceptibility among Staphylococcus aureusisolates ...
The incidence of hetero-intermediate glycopeptidesusceptibility among Staphylococcus aureusisolates ...
The incidence of hetero-intermediate glycopeptidesusceptibility among Staphylococcus aureusisolates ...
The incidence of hetero-intermediate glycopeptidesusceptibility among Staphylococcus aureusisolates ...
ABSTRACTClinical isolates of methicillin-resistant Staphylococcus aureus (n = 1070) collected from 6...
ABSTRACTStaphylococcus aureus isolates were screened for reduced susceptibility to glycopeptides wit...
ABSTRACTStaphylococcus aureus strains with decreased susceptibility to glycopeptides (GISA) have bee...
Glycopeptide resistance in Staphylococcus aureus is a source of great concern because, especially in...
Objectives To determine the incidence of Staphylococcus aureus isolates with reduced susceptibility ...
AbstractMethicillin-resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen worldwide....
International audienceOBJECTIVES: Glycopeptides are the drugs of choice to treat infections due to m...
Abstract : Staphylococcus aureus with resistance to glycopeptide antibiotics has been considered to ...
The glycopeptides (particularly vancomycin) have been the recommended therapy for serious methicilli...
AbstractVancomycin resistance in Staphylococcus aureus has emerged over the last ten years due to va...
We evaluated, by an improved susceptibility testing method, the prevalence and significance of low-l...